Underscoring concerns about ongoing drug shortages, two different ventures representing hundreds of hospitals across the U.S. are announcing separate deals on Wednesday in which manufacturers have agreed to provide medicines that are in short supply.
In the first deal, CivicaRx, which is a generic drug company formed by several large hospital systems and three philanthropies, has reached an agreement for Xellia Pharmaceuticals to manufacture antibiotics, including vancomycin and daptomycin. The deal marks the first such arrangement since CivicaRx launched several months ago. About 900 hospitals are part of the CivicaRx network.
About the Author Reprints
